Rivaroxaban Ethylamino Analog (2HCl Salt)
✓
데이터 정확도 100%
연중무휴 과학적 지원
⬡
제품 품질에 대한 무관용 원칙

재고 위치

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

Rivaroxaban Ethylamino Analog (2HCl Salt)

● 재고 있음

카탈로그 번호:VE0027969
CAS 번호:N/A
분자식:C18H22Cl3N3O4S
분자량:482.81 g/mol

에 대한 추가 정보

모약물

Rivaroxaban

IUPAC명

1-amino-3-((4-(3-oxomorpholino)phenyl)amino)propan-2-yl 5-chlorothiophene-2-carboxylate dihydrochloride

Pharmacopeial Synonyms

N/A

동의어

N/A

SMILES

O=C(C1=CC=C(Cl)S1)OC(CNC2=CC=C(N3C(COCC3)=O)C=C2)CN.[H]Cl.[H]Cl

InChI

InChI=1S/C18H20ClN3O4S.2ClH/c19-16-6-5-15(27-16)18(24)26-14(9-20)10-21-12-1-3-13(4-2-12)22-7-8-25-11-17(22)23;;/h1-6,14,21H,7-11,20H2;2*1H

설명

Rivaroxaban ethylamino analog (2HCl salt) is a characterized process-related impurity observed during rivaroxaban manufacture and stability studies. This impurity exhibits distinct mass spectral and chromatographic behavior, facilitating identification by LC-MS/MS and HPLC-UV methods. Analytical profiling indicates potential formation via ethylamine incorporation or salt transformation under acidic conditions, making it a relevant target for impurity profiling, method validation, and stability-indicating assays. Control strategies include specification setting, limit establishment and use as a reference material for forced degradation studies and batch release testing. Detailed impurity data support regulatory submissions and quality risk assessments for rivaroxaban drug substance manufacturing.

견적 요청

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url